1 completed, 1 recruiting, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Immune Complex Diseases: new trials by email Literature Review of Immune Complex Diseases trials Research Report on Immune Complex Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Ravulizumab in Pediatric Participants With Primary IgAN Ravulizumab - IgAN, IgAVN | Phase 3 | Recruiting | Alexion Pharmaceuticals, Inc. | 36 | 2025-06-14 | 2026-07-30 |
| Evaluation of Glucocorticoids Plus Rituximab in Patients With Newly-Diagnosed or Relapsing IgA Vasculitis Rituximab Injection, placebo - IgA Vasculitis | Phase 3 | Completed | Hopital Foch | 75 | 2022-03-11 | 2026-06-11 |
| Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis Colchicine - IgA Vasculitis | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 264 | 2019-11-12 | 2021-10-04 |
IgA Vasculitis (3) · Glomerulonephritis, IGA (1) · Proteinuria (1)
Blood Coagulation Disorders (3) · Cardiovascular Diseases (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Hemorrhage (3) · Hemorrhagic Disorders (3) · Hemostatic Disorders (3) · Hypersensitivity (3) · Immune System Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Purpura (3) · Signs and Symptoms (3) · Skin Diseases (3)
Colchicine (1) · Rituximab (1) · ravulizumab (1)
Alexion Pharmaceuticals, Inc. (1) · Assistance Publique - Hôpitaux de Paris (1) · Hopital Foch (1)
France (2) · China (1) · Italy (1) · Japan (1) · South Korea (1) · Spain (1) · Taiwan (1) · United States (1)
Romain Paule, Dr (1)
PMID 12401245, PMID 28605168, PMID 42384439
2018 (1)